Oberbauer R, Haas M, Regele H, Barnas U, Schmidt A, Mayer G
Department of Internal Medicine III, University of Vienna, Austria.
J Clin Invest. 1995 Jul;96(1):22-9. doi: 10.1172/JCI118024.
To characterize the defect in glomerular permselectivity responsible for proteinuria after renal transplantation, we studied 10 patients with moderate proteinuria (median 0.37 g/d, range 0.20-0.79), 16 patients with the nephrotic syndrome (6.73 g/d, 3.9-14.6), 8 living related donor transplant recipients without any history of rejection (median proteinuria 0.26 g/d, 0.06-0.58), and 12 healthy volunteers. The fractional clearance of neutral dextrans > 54 A was significantly higher in nephrotic patients, demonstrating a defect in glomerular size selectivity. Using a log-normal model of glomerular pore size distribution, r*(5%) and r*(1%), indices for the presence of large pores, were increased in the nephrotic patients. The fractional clearance of negatively charged dextran sulfate was significantly higher in all patient groups, indicating a loss of glomerular charge selectivity. Biopsy findings showed more prominent glomerular lesions in the nephrotic group compared with the moderately proteinuric group. We conclude that mild proteinuria late after renal transplantation is associated with a defect in glomerular charge selectivity. The development of nephrotic range proteinuria is associated also with a defect of glomerular size selectivity, which correlates with prominent glomerular pathology.
为了明确肾移植后导致蛋白尿的肾小球滤过屏障缺陷的特征,我们研究了10例中度蛋白尿患者(中位数0.37 g/d,范围0.20 - 0.79)、16例肾病综合征患者(6.73 g/d,3.9 - 14.6)、8例无任何排斥反应病史的活体亲属供肾移植受者(蛋白尿中位数0.26 g/d,0.06 - 0.58)以及12名健康志愿者。肾病患者中大于54 Å的中性右旋糖酐的分数清除率显著更高,表明肾小球大小选择性存在缺陷。使用肾小球孔径分布的对数正态模型,肾病患者中r*(5%)和r*(1%)(大孔存在的指标)升高。所有患者组中带负电荷的硫酸葡聚糖的分数清除率均显著更高,表明肾小球电荷选择性丧失。活检结果显示,与中度蛋白尿组相比,肾病组的肾小球病变更突出。我们得出结论,肾移植后期的轻度蛋白尿与肾小球电荷选择性缺陷有关。肾病范围蛋白尿的发生还与肾小球大小选择性缺陷有关,这与显著的肾小球病理改变相关。